LTRN Earnings

Quarterly EPS
$-0.42
Q3 2024
$-0.54
Q4 2024
$-0.42
Q1 2025
$-0.40
Q2 2025
$-0.39
Q3 2025
$-0.36
Q4 2025
$-0.30
Q1 2026
$-0.57
Q2 2026
Latest RevenueN/A
Latest Net Income-7072124
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.570-7072124-42.5%
Q1 2026-$0.300-3329171+28.6%
Q4 2025-$0.360-4074217+33.3%
Q3 2025-$0.390-4177423+7.1%
Q2 2025-$0.400-4331015+13.0%
Q1 2025-$0.420-4536783+17.6%
Q4 2024-$0.540-5875200-38.5%
Q3 2024-$0.420-4505697-44.8%
Q2 2024-$0.460-4959506
Q1 2024-$0.510-5440810
Q4 2023-$0.390-4185921
Q3 2023-$0.290-3161450
Lantern Pharma (LTRN) — Earnings